Table 6 Clinical outcome for patients with cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae bacteremia cases
pre-CPDX screening (n = 63) | CPDX screening (n = 84) | p-value | |
|---|---|---|---|
Primary outcome | |||
Modifications were made to the administration of susceptible antimicrobial agent within 24 h of blood culture-positive report, n (%) | 4 (6.3) | 19 (22.6) | 0.010 |
Secondary outcome | |||
30-day mortality, n (%) | 4 (6.3) | 4 (4.9) | 0.728 |
Hospital mortality, n (%) | 5 (7.9) | 5 (6.1) | 0.747 |
Length of hospital stays from blood culture collection (days), median [IQR] | 14.00 [11.00–28.50] | 13.50 [9.25–26.75] | 0.561 |
Cost of intravenous antibiotic therapy (yen), median [IQR] | 19035.00 [8410.50–30301.50] | 16465.00 [10422.00–24408.00] | 0.560 |